Renal Graft Function After Treatment With Erythropoietin (EPO)

NCT01450878 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Lack of patients eligible for the study.

Conditions

Ischemia

Interventions

DRUG: beta-epoietin

Sponsor

University Hospital, Limoges

Collaborators

[object Object]